Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2015

View Archived Issues

Daiichi Sankyo advances pipeline in first quarter of fiscal 2015

Simulation-guided DNA probes designed to improve specificity of NA hybridization

MedImmune and Amgen start phase IIa trial of AMG-557 in Sjogren's syndrome

Sunshine Lake Pharma develops FXa inhibitors

Wockhardt divulges beta-lactamase inhibitors

Euclises Pharmaceuticals designs COX-2 inhibitors/NO donors

4D Pharma and APC Microbiome Institute to investigate live biotherapeutics for autism

Kwang Dong licenses South Korean rights to Contrave

Ono Pharmaceutical reviews events of first quarter of fiscal 2015

Celsion provides update on phase III trials of ThermoDox in HCC

LSK BioPharma in-licenses BTK inhibitor HCI-1401

Preclinical evidence that ET-B receptor agonism slows Alzheimer’s Disease progression

Hetero launches biosimilar rituximab in India

Antisense therapy proved effective in reducing triglyceride levels

Cold Genesys secures funding for immunotherapy trials

Sanofi and Evotec to collaborate on beta-cell-targeting therapies for diabetes

Dr. Reddy's to market three Amgen products in India

AstraZeneca discloses DPP1 inhibitors

Sunshine Lake patents HCV NS5A inhibitors

Cellceutix begins phase II trial of Prurisol for psoriasis

Lundbeck joins Global Alzheimer's Platform

Antiva Biosciences raises funds to advance lead compound for HPV

Allergan starts phase I trial of dry eye candidate AGN-232411

Varlitinib receives orphan drug designation from the FDA for cholangiocarcinoma

The FDA grants orphan drug designation to daratumumab for follicular lymphoma

New York State grants conditional approval for Rosetta Genomics' lung biomarker

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...